Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis

Arthritis Research

Volumn 2, Issue 5, 2000, Pages 361-367

  Pap, Thomas ^a   Müller Ladner, Ulf ^b   Gay, Renate E ^a   Gay, Steffen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Fibroblasts; Rheumatoid arthritis

Indexed keywords

CATHEPSIN; CELL ADHESION MOLECULE; CELL MARKER; CYTOKINE; MATRIX METALLOPROTEINASE;

AGGRESSIVENESS; APOPTOSIS; CELL ACTIVATION; CELL ADHESION; CELL STIMULATION; CELL TYPE; CYTOLOGY; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; JOINT DESTRUCTION; LYMPHOCYTE; MACROPHAGE; MOLECULAR DYNAMICS; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; REGULATOR GENE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE;

ANIMALS; ARTHRITIS, RHEUMATOID; FIBROBLASTS; HUMANS; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE;

EID: 0034469496     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar113     Document Type: Review

References (77)

1. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: Two cellular mechanisms explain joint destruction?
2. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?
3. Has research on lymphocytes hindered progress in rheumatoid arthritis?
4. T-cell independent joint destruction
5. Histomorphological basis of articular cartilage destruction in rheumatoid arthritis
6. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids
7. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice
8. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective
9. Effect of dominant negative mutants of raf-1 and c-myc on rheumatoid arthritis synovial fibroblasts in the SCID mouse model
10. Activation of synovial fibroblasts in rheumatoid arthritis: Lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction
11. Constitutive expression of c-fos and c-jun, over-expression of ets-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis
12. Measurement of transcription factor c-fos and EGR-1 mRNA transcription levels in synovial tissue by quantitative RT-PCR
13. Modified expression of c-Fos and c-Jun proteins and production of interleukin-1 beta in patients with rheumatoid arthritis
14. Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts
15. Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium
16. The AP-1 site and MMP gene regulation: What is all the fuss about?
17. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
18. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis
19. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue
20. Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis
21. Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1 beta-stimulated synovial fibroblasts
22. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium
23. Inhibition of endogenous p53 by gene transfer increases the invasiveness of fibroblast-like synoviocytes in the SCID mouse model of rheumatoid arthritis (RA)
24. Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts
25. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
26. Impaired Fas response and autoimmunity in Ptent+/-mice
27. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferation cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining
28. C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes
29. Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis
30. Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients
31. 3H-thymidine incorporating cells in rheumatoid arthritis synovial membrane
32. Proliferation of pannus tissue cells in rheumatoid arthritis
33. Apoptosis in rheumatoid arthritis synovium
34. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes
35. Apomodulation as a novel therapeutic concept for the regulation of apoptosis in rheumatoid synoviocytes
36. Expression of sentrin, a novel anti-apoptotic molecule at sites of synovial invasion in rheumatoid arthritis
37. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin
38. Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins
39. An immunohistochemical and immunoelectron microscopic study of adhesion molecules in synovial pannus formation in rheumatoid arthritis
40. Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry
41. Integrins, oncogenes, and anchorage independence
42. Cell adhesion induces expression of growth-associated genes in suspension-arrested fibroblasts
43. Integrin-dependent induction of early growth response genes in capillary endothelial cells
44. Cysteine proteinases in arthritis and inflammation
45. In situ hybridization studies on stromelysin and collagenase mRNA expression in rheumatoid synovium
46. Expression of stromelysin and TIMP in rheumatoid arthritis synovium
47. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: Destruction from above
48. Significance of serine proteinase and matrix metalloproteinase systems in the destruction of human articular cartilage
49. Matrix-metalloproteinase 13 (collagenase 3) in human rheumatoid synovium
50. The measurement of collagenase, TIMP and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis
51. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): Correlation with rheumatoid arthritis
52. Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis
53. Differential expression of membrane-type matrix metalloproteinases (MT-MMPs) in rheumatoid arthritis (RA)
54. A matrix metalloproteinase expressed on the surface of invasive tumour cells
55. Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis
56. Synovial fibroblast-like cell transfection with the SV40 large T antigen induces a transformed phenotype and permits transient tumor formation in immunodeficient mice
57. Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis
58. Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells
59. Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor alpha and interleukin-1
60. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction
61. Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy
62. TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis
63. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
64. Distribution of TNF-α, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-α is distributed mainly in the vicinity of TNF receptors in the deeper layers
65. Different roles of TNFα and IL-1 in murine streptococcal wall arthritis
66. Effects of interleukin 1 receptor antagonist alone and in combination with methotrexate in adjuvant arthritic rats
67. Mechanisms of bone loss in inflammatory arthritis: Diagnosis and therapeutic implications
68. Rheumatoid arthritis (RA) synovial fibroblasts express osteoclast differentiating factor (ODF) mRNA at sites of joint destruction
69. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue
70. + T-cells in rheumatoid arthritis
71. + T cells
72. Inhibition of T cell apoptosis in the rheumatoid synovium
73. Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells
74. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model
75. Gene therapy in osteoarticular diseases: Where are we?
76. Gene therapy in rheumatoid arthritis: How to target joint destruction?